Green Biologics Appoints New Member to Board of Directors
GAHANNA, OH/ABINGDON, UK – Green Biologics (GBL) has appointed James J. Hohman to a non-executive director position on the company’s Board of Directors. Hohman was formerly President of OMNOVA Solutions’ Performance Chemicals business unit and a corporate Senior Vice President of OMNOVA.
Prior to GenCorp/OMNOVA, Hohman held key general management, business and marketing management positions with BP Chemicals and B.F. Goodrich.
“Jim is a seasoned leader and executive in the chemicals industry, and we are excited to welcome him to Green Biologics’ Board of Directors,” said Sean Sutcliffe, Green Biologics’ CEO. “We believe his strong experience in growth, both through acquisitions and through organic growth, as well as his global experience, will be extremely valuable as Green Biologics emerges as a leader in renewable chemicals.”
In his 19 years at OMNOVA and GenCorp, Hohman was instrumental in broadening the company’s global reach in emulsion polymers and specialty chemicals to include applications around the world in oil and gas, construction, high-performance coatings, nonwovens, adhesives, automotive, polymer and rubber modification, antioxidants, coated paper and packaging, carpet and flooring, and many others.
At OMNOVA/GenCorp, he led negotiations for a number of key acquisitions including the Goodyear/Calhoun, Georgia latex facility, the U.S. specialty chemicals businesses of Sequa Chemicals and PolymerLatex, and the acquisition of ELIOKEM.